BNGO
Bionano Genomics, Inc.$1.56+0.23 (+16.92%)Prev Close$1.33·MCap$3.7M·P/E—·Vol38.40M·Yield—
▲
Buys (12M)
2
$9.7K
▼
Sells (12M)
5
$107.80
◆
Net Activity
Net Buyer
$9.6K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Bionano Genomics, Inc. (BNGO) has been dominated by buying, with 2 insider purchases totaling $9.7K and 5 insider sales totaling $107.80. The most recent insider transaction was by Luderer Albert (director, officer: Interim Chief Executive), who purchased $4.8K worth of shares on Sep 9, 2026. Bionano Genomics, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $3.7M.
BNGO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Luderer Albert | director, officer: Interim Chief Executive | Buy | 4,000 | $1.21 | $4.8K | 8,000+100% |
| Aug 21, 2026 | Luderer Albert | director, officer: Interim Chief Executive | Buy | 4,000 | $1.22 | $4.9K | 4,000 |
| Feb 18, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 18 | $1.10 | $19.80 | 0 |
| Feb 17, 2026 | Adamchak Mark | Principal Accounting Officer | Sell | 3 | $1.10 | $3.30 | 0 |
| Feb 17, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 6 | $1.10 | $6.60 | 0 |
| Feb 17, 2026 | Holmlin R. Erik | PRESIDENT AND CEO | Sell | 51 | $1.10 | $56.10 | 0 |
| Feb 17, 2026 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 20 | $1.10 | $22.00 | 0 |
| Sep 11, 2025 | Chaubey Alka | Chief Medical Officer | Sell | 51 | $4.06 | $207.06 | 0 |
| Sep 11, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 59 | $4.06 | $239.54 | 0 |
| Jun 3, 2025 | Adamchak Mark | Principal Accounting Officer | Sell | 7 | $3.69 | $25.83 | 0 |
| Jun 3, 2025 | Chaubey Alka | Chief Medical Officer | Sell | 24 | $3.69 | $88.56 | 0 |
| Jun 3, 2025 | Dixon Jonathan V. | General Counsel | Sell | 25 | $3.69 | $92.25 | 0 |
| Jun 3, 2025 | Holmlin R. Erik | President and CEO | Sell | 75 | $3.69 | $276.75 | 0 |
| Jun 3, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 27 | $3.69 | $99.63 | 0 |
| Mar 14, 2025 | Holmlin R. Erik | President and CEO | Sell | 198 | $3.47 | $687.06 | 0 |
| Feb 15, 2025 | Adamchak Mark | Principal Accounting Officer | Sell | 4 | $5.73 | $22.92 | 0 |
| Feb 15, 2025 | Chaubey Alka | Chief Medical Officer | Sell | 18 | $5.73 | $103.14 | 0 |
| Feb 15, 2025 | Dixon Jonathan V. | General Counsel | Sell | 6 | $5.73 | $34.38 | 0 |
| Feb 15, 2025 | Holmlin R. Erik | President and CEO | Sell | 51 | $5.73 | $292.23 | 0 |
| Feb 15, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 20 | $5.73 | $114.60 | 0 |
| Sep 11, 2024 | Chaubey Alka | Chief Medical Officer | Sell | 3,075 | $0.48 | $1.5K | 0 |
| Sep 11, 2024 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 3,568 | $0.48 | $1.7K | 0 |
| Feb 15, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 1,081 | $1.27 | $1.4K | 0 |
| Feb 15, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 402 | $1.27 | $510.54 | 0 |
| Feb 15, 2024 | Holmlin R. Erik | PRESIDENT AND CEO | Sell | 3,073 | $1.27 | $3.9K | 0 |
| Feb 15, 2024 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 1,229 | $1.27 | $1.6K | 0 |
| Jun 13, 2023 | Mamuszka Hannah | Director | Buy | 65,789 | $0.76 | $50.0K2.0% OS | 0 |
| May 16, 2023 | Holmlin R. Erik | President and CEO | Buy | 15,000 | $0.64 | $9.6K | 0 |
| May 12, 2023 | Holmlin R. Erik | President and CEO | Sell | 50,141 | $0.66 | $33.1K1.5% OS | 0 |
| May 12, 2023 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 41,496 | $0.66 | $27.4K1.3% OS | 0 |
| May 12, 2023 | Stewart Christopher P. | Chief Financial Officer | Buy | 50,000 | $0.67 | $33.4K1.5% OS | 0 |
| Aug 15, 2022 | Linney Yvonne | Director | Sell | 20,000 | $3.62 | $72.4K0.6% OS | 0 |
| May 16, 2022 | BARKER DAVID L | Director | Buy | 10,000 | $1.60 | $16.0K | 0 |
| May 12, 2022 | Holmlin R. Erik | President and CEO | Sell | 50,141 | $1.41 | $70.7K1.5% OS | 0 |
| May 12, 2022 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 41,496 | $1.41 | $58.5K1.3% OS | 0 |
| Nov 29, 2021 | Holmlin R. Erik | President and CEO | Buy | 5,025 | $3.99 | $20.0K | 0 |
BNGO Insider Buying Activity
The following table shows recent insider purchases of Bionano Genomics, Inc. (BNGO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Luderer Albert | director, officer: Interim Chief Executive | Buy | 4,000 | $1.21 | $4.8K | 8,000+100% |
| Aug 21, 2026 | Luderer Albert | director, officer: Interim Chief Executive | Buy | 4,000 | $1.22 | $4.9K | 4,000 |
| Jun 13, 2023 | Mamuszka Hannah | Director | Buy | 65,789 | $0.76 | $50.0K2.0% OS | 0 |
| May 16, 2023 | Holmlin R. Erik | President and CEO | Buy | 15,000 | $0.64 | $9.6K | 0 |
| May 12, 2023 | Stewart Christopher P. | Chief Financial Officer | Buy | 50,000 | $0.67 | $33.4K1.5% OS | 0 |
| May 16, 2022 | BARKER DAVID L | Director | Buy | 10,000 | $1.60 | $16.0K | 0 |
| Nov 29, 2021 | Holmlin R. Erik | President and CEO | Buy | 5,025 | $3.99 | $20.0K | 0 |
BNGO Insider Selling Activity
The following table shows recent insider sales of Bionano Genomics, Inc. (BNGO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 18 | $1.10 | $19.80 | 0 |
| Feb 17, 2026 | Adamchak Mark | Principal Accounting Officer | Sell | 3 | $1.10 | $3.30 | 0 |
| Feb 17, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 6 | $1.10 | $6.60 | 0 |
| Feb 17, 2026 | Holmlin R. Erik | PRESIDENT AND CEO | Sell | 51 | $1.10 | $56.10 | 0 |
| Feb 17, 2026 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 20 | $1.10 | $22.00 | 0 |
| Sep 11, 2025 | Chaubey Alka | Chief Medical Officer | Sell | 51 | $4.06 | $207.06 | 0 |
| Sep 11, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 59 | $4.06 | $239.54 | 0 |
| Jun 3, 2025 | Adamchak Mark | Principal Accounting Officer | Sell | 7 | $3.69 | $25.83 | 0 |
| Jun 3, 2025 | Chaubey Alka | Chief Medical Officer | Sell | 24 | $3.69 | $88.56 | 0 |
| Jun 3, 2025 | Dixon Jonathan V. | General Counsel | Sell | 25 | $3.69 | $92.25 | 0 |
| Jun 3, 2025 | Holmlin R. Erik | President and CEO | Sell | 75 | $3.69 | $276.75 | 0 |
| Jun 3, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 27 | $3.69 | $99.63 | 0 |
| Mar 14, 2025 | Holmlin R. Erik | President and CEO | Sell | 198 | $3.47 | $687.06 | 0 |
| Feb 15, 2025 | Adamchak Mark | Principal Accounting Officer | Sell | 4 | $5.73 | $22.92 | 0 |
| Feb 15, 2025 | Chaubey Alka | Chief Medical Officer | Sell | 18 | $5.73 | $103.14 | 0 |
| Feb 15, 2025 | Dixon Jonathan V. | General Counsel | Sell | 6 | $5.73 | $34.38 | 0 |
| Feb 15, 2025 | Holmlin R. Erik | President and CEO | Sell | 51 | $5.73 | $292.23 | 0 |
| Feb 15, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 20 | $5.73 | $114.60 | 0 |
| Sep 11, 2024 | Chaubey Alka | Chief Medical Officer | Sell | 3,075 | $0.48 | $1.5K | 0 |
| Sep 11, 2024 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 3,568 | $0.48 | $1.7K | 0 |
| Feb 15, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 1,081 | $1.27 | $1.4K | 0 |
| Feb 15, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 402 | $1.27 | $510.54 | 0 |
| Feb 15, 2024 | Holmlin R. Erik | PRESIDENT AND CEO | Sell | 3,073 | $1.27 | $3.9K | 0 |
| Feb 15, 2024 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 1,229 | $1.27 | $1.6K | 0 |
| May 12, 2023 | Holmlin R. Erik | President and CEO | Sell | 50,141 | $0.66 | $33.1K1.5% OS | 0 |
| May 12, 2023 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 41,496 | $0.66 | $27.4K1.3% OS | 0 |
| Aug 15, 2022 | Linney Yvonne | Director | Sell | 20,000 | $3.62 | $72.4K0.6% OS | 0 |
| May 12, 2022 | Holmlin R. Erik | President and CEO | Sell | 50,141 | $1.41 | $70.7K1.5% OS | 0 |
| May 12, 2022 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 41,496 | $1.41 | $58.5K1.3% OS | 0 |
BNGO Insiders
Similar Stocks to BNGO
TMO
Thermo Fisher Scientific Inc.
$639.25+4.20%
$225.09B
DHR
Danaher Corporation
$209.09+2.92%
$144.11B
NTRA
Natera, Inc.
$350.89+2.66%
$47.31B
IQV
IQVIA Holdings Inc.
$269.85+1.61%
$42.30B
A
Agilent Technologies, Inc.
$150.25+2.38%
$40.89B
IDXX
IDEXX Laboratories, Inc.
$511.41+0.36%
$40.64B
ILMN
Illumina, Inc.
$223.77+7.55%
$31.24B
WAT
Waters Corporation
$417.37+1.79%
$30.54B